Food and Drug Administration

"The attorneys general of New York, California, Massachusetts, and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, the so-called “abortion pill.” The four states have requested that the FDA remove the mifepristone risk evaluation and mitigation strategies (REMS) program, “including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form.” The states have dubbed these requirements “unnecessary, duplicative, and burdensome.”  The FDA approved mifepristone (brand name “Mifeprex”) more than 20 years ago based on a comprehensive review of scientific evidence. As of 2016, mifepristone has been deemed…